Effervescent Pain Relief Interactions
There are 476 drugs known to interact with Effervescent Pain Relief (aspirin/citric acid/sodium bicarbonate), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 70 are major, 338 are moderate, and 68 are minor.
- View all 476 medications that may interact with Effervescent Pain Relief
- View Effervescent Pain Relief alcohol/food interactions (2)
- View Effervescent Pain Relief disease interactions (11)
Most frequently checked interactions
View interaction reports for Effervescent Pain Relief (aspirin/citric acid/sodium bicarbonate) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen
- albuterol
- Alcohol (contained in alcoholic beverages) (ethanol)
- alprazolam
- Ambien (zolpidem)
- aspirin
- atenolol
- Ativan (lorazepam)
- atorvastatin
- azelastine nasal
- Azo Urinary Pain Relief (phenazopyridine)
- benzonatate
- Blisovi Fe 1.5 / 30 (ethinyl estradiol / norethindrone)
- budesonide
- BuSpar (buspirone)
- Cipro (ciprofloxacin)
- ciprofloxacin
- Claritin (loratadine)
- clonazepam
- Concerta (methylphenidate)
- Coricidin HBP Cold & Flu (acetaminophen / chlorpheniramine)
- empagliflozin
- enoxaparin
- famotidine
- ferrous sulfate
- furosemide
- L-Lysine (lysine)
- lisinopril
- nitrofurantoin
Effervescent Pain Relief alcohol/food interactions
There are 2 alcohol/food interactions with Effervescent Pain Relief (aspirin/citric acid/sodium bicarbonate).
Effervescent Pain Relief disease interactions
There are 11 disease interactions with Effervescent Pain Relief (aspirin/citric acid/sodium bicarbonate) which include:
- sodium/water balance
- coagulation
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- acid/base balance
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
Report options
More about Effervescent Pain Relief (aspirin/citric acid/sodium bicarbonate)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.